Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope

• Ángela Covo-Vergara,
• Laura Salaberry,
• Noelia Silva-Pilipich,
• Sandra Hervas-Stubbs,
• Cristian Smerdou

Affiliations

Ángela Covo-Vergara

Division of Cancer, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain

Laura Salaberry

Division of DNA and RNA Medicine, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain; Nanogrow Biotech, Montevideo, Uruguay

Noelia Silva-Pilipich

Division of DNA and RNA Medicine, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain; Nanogrow Biotech, Montevideo, Uruguay

Sandra Hervas-Stubbs

Division of Cancer, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain

Cristian Smerdou

Division of DNA and RNA Medicine, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, Pamplona, Spain; Corresponding author: Cristian Smerdou, Division of DNA and RNA Medicine, Cima Universidad de Navarra, Av. Pío XII 55, 31008 Pamplona, Spain.